Glutamate receptor genes as candidates for schizophrenia susceptibility

Drug Development Research

Volumn 60, Issue 2, 2003, Pages 137-151

  Fukumaki, Yasuyuki ^a   Shibata, Hiroki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antipsychotic drug; Association study; Endophenotype; Gene manipulated mice; Glutamate receptor; GRIA4; GRIK1; GRIK2; GRIN1; GRM2; GRM3; Haplotype; Linkage disequilibrium (LD); Schizophrenia; SNP

Indexed keywords

AMPA RECEPTOR; CLOZAPINE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; EGLUMETAD; GLUTAMATE RECEPTOR; HALOPERIDOL; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

AUTOPSY; BINDING KINETICS; DISEASE EXACERBATION; DNA DETERMINATION; DRUG RECEPTOR BINDING; DRUG TARGETING; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRIA4 GENE; GRIK1 GENE; GRIK2 GENE; GRIN1 GENE; GRM2 GENE; GRM3 GENE; HAPLOTYPE; HUMAN; LEARNING; MEMORY; NEUROTRANSMISSION; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; SEXUAL BEHAVIOR; SIDE EFFECT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SOCIAL INTERACTION; TRANSGENIC MOUSE;

EID: 0141997717     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10293     Document Type: Review

References (93)

1. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE Jr, Jones EG. 1996. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16:19-30.
2. Arinami T, Ishiguro H, Minowa Y, Ohtsuki T, Tsujishita T, Imamura A, Yoshikawa T, Toyota T, Kamada K, Shimizu H, Yoshitsugu K, Shibata H, Fujii Y, Fukumaki Y, Tashiro N, Inada T, Iijima Y, Kitao Y, Furuno T, Someya T, Muratake T, Kaneko N, Tsuji S, Mineta M, Takeichi M, Ujike H, Takeshita Y, Tanaka Y, Nakata K, Kitajima T, Nishiyama T, Yamanouchi Y, Iwata N, Ozaki N, Ohara K, Ohmori O, Shinkai T, Hori H, Nakamura J, Kojima T, Takahashi S, Tanabe E, Yara K, Nanko S, Yoneda H, Kusumi I, Kameda K, Koyama T, Fukuzako H, Hashiguchi T, Tanabe K, Okazaki Y, 2003. Initial genome-wide scan for linkage with schizophrenia in Japanese Schizophrenia Sib-pair Linkage Group (JSSLG) families. Am J Med Genet 120B:22-28.
3. Bai G, Kusiak JW. 1995. Functional analysis of the proximal 5′-flanking region of the N-methyl-D-aspartate receptor subunit gene, NMDAR1. J Biol Chem 270:7737-7744.
4. Begni S, Popoli M, Moraschi S, Bignotti S, Tura GB, Gennarelli M. 2002 Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia. Mol Psychiatry 7:416-418.
5. Belsham B. 2001. Glutamate and its role in psychiatric illness. Hum Psychopharmacol 16:139-146.
6. Benes FM, Todtenkopf MS, Kostoulakos P. 2001. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11:482-491.
7. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Pulver AE, et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20:70-73.
8. Bolonna AA, Kerwin RW, Munro J, Arranz MJ, Makoff AJ. 2001. Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophr Res 47:99-103.
9. Bray NJ, Williams NM, Bowen T, Cardno AG, Gray M, Jones LA, Murphy KC, Sanders RD, Spurlock G, Odonovan MC, Owen MJ. 2000. No evidence for association between a non-synonymous polymorphism in the gene encoding human metabotropic glutamate receptor 7 and schizophrenia. Psychiatr Genet 10:83-86.
10. Breese CR, Freedman R, Leonard SS. 1995. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674:82-90.
11. Cartmell J, Schoepp DD. 2000. Regulation of neurotransmitter release by metabotropic glutamate receptors. Neurochemistry 75:889-907.
12. Cartmell J, Salhoff CR, Perry KW, Monn JA, Schoepp DD. 2000. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Res 887:378-384.
13. Chen AC, Kalsi G, Brynjolffson J, Sigmundsson T, Curtis D, Butler R, Read T, Murphy P, Petursson H, Barnard EA, Gurling HM. 1996. Lack of evidence for close linkage of the glutamate GluR6 receptor gene with schizophrenia. Am J Psychiat 153:1634-1636.
14. Chen AC, Kalsi G, Brynjolfsson J, Sigmundsson T, Curtis D, Butler R, Read T, Murphy P, Petursson H, Barnard EA, Gurling HM. 1997. Exclusion of linkage of schizophrenia to the gene for the glutamate GluR5 receptor. Biol Psychiat 41:243-245.
15. Cochilla AJ, Alford S. 1998. Metabotropic glutamate receptor-mediated control of neurotransmitter release. Neuron 20:1007-1016.
16. Crook JM, Akil M, Law BC, Hyde TM, Kleinman JE. 2002. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects. Mol Psychiat 7:157-164.
17. Devon RS, Anderson S, Teague PW, Muir WJ, Murray V, Pelosi AJ, Blackwood DH, Porteous DJ. 2001. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol Psychiat 6:311-314.
18. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. 1995. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 29:211-223.
19. Eastwood SL, Burnet PW, Harrison PJ. 1997a, GluB2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Brain Res Mol Brain Res 44:92-98.
20. Eastwood SL, Kerwin RW, Hanison PJ. 1997b. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiat 41:636-643.
21. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, Juvonen H, Varilo T, Arajarvi R, Kokko-Sahin ML, Lonnqvist J, Peltonen L 2000. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 9:1049-1057.
22. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkavy Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. 1998. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 81:290-295.
23. Fujii Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N, Shibata A, Ninomiya H, Tashiro N, Fukumaki Y. 2003. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 18:72-76.
24. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. 2000. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiat 157:1141-1149.
25. Garver DL, Holcomb J, Mapua FM, Wilson R, Barnes B. 2001. Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigrees. Schizophr Res 52:145-160.
26. Gottesman PE. 1995 Schizophrenia genesis: The origins of madness. New York: Freeman.
27. Gregor P, O'Hara BF, Yang X, Uhl GR. 1993. Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. Neuroreport 4:1343-1346.
28. Grimwood S, Slater P, Deakin JF, Hutson PH. 1999. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 10:461-465.
29. Harrison PJ, McLaughlin D, Kerwin RW. 1991. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337:450-452.
30. Healy DJ, Meador-Woodruff JH. 1996. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res 708:38-44.
31. Healy DJ, Meador-Woodruff JH. 1997. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum. Brain Res Mol Brain Res 47:331-338.
32. Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ, Meador-Woodruff JH. 1998. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology 19:278-286.
33. Herb A, Burnashev N, Werner P, Sakmann B, Wisden W, Seeburg PH. 1992. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8:775-785.
34. Hickmott PW, Constantine-Paton M. 1997. Experimental down-regulation of the NMDA channel associated with synapse pruning. J Neurophysiol 78:1096-1107.
35. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. 1993. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75:1361-1370.
36. Holscher C, Gigg J, O'Mara SM. 1999. Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning and neurotoxicity. Neurosci Biobehav Rev 23:399-410.
37. Hoover F, Hankin MH, Radel JD, Reese JS, Goldman D. 1997. Axon-target interactions maintain synaptic gene expression in retinae transplanted to intracranial regions of the rat. Brain Res Mol Brain Res 51:123-132.
38. Hong CJ, Yu YW, Lin CH, Cheng CY, Tsai SJ. 2001. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr Genet 11:219-222.
39. Humphries C, Mortimer A, Hirsch S, de Belleroche J. 1996. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport 7:2051-2055.
40. Hung CC, Chen HY, Chen CH. 2002. 2002 Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene(GRIN1) in schizophrenic patients. Psychiatr Genet 12:225-230.
41. Ibrahim HM, Hogg AJ, Jr., Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. 2000. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiat 157:1811-1823.
42. Itil T, Keskiner A, Kiremitei N, Holden JM. 1967. Effect of phencyclidine in chronic schizophrenics. Can Psychiatr Assoc J 12:209-212.
43. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiat 148:1301-1308.
44. Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y. 2001. Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol Psychiat 6:186-192.
45. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B. 1980. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-382.
46. Lahiri DK, Nurnberger JI, Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
47. Lahti AC, Koffel B, LaPorte D, Tamminga CA. 1995. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
48. Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, Sherrington R, Adolfsson R, Jazin E. 2001. A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet 69:96-105.
49. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder JC. 1997. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. Neuroscience 17:5196-5205.
50. Makino C, Fujii Y, Kikuta R, Hirata N, Tani A, Shibata A, Ninomiya H, Tashiro N, Shibata H, Fukumaki Y. 2003. Positive association of the AMPA receptor subunit GluR4 (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. Am J Med Genet 116B:17-22.
51. Martí SB, Cichon S, Propping P, Nothen M. 2002. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am J Med Genet 114:46-50.
52. Martucci L, Wong AH, Trakalo J, Cate-Carter T, Wong GW, Macciardi FM, Kennedy JL. 2003. N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses. Am J Med Genet 119B:24-27.
53. McGuffin P, Owen MJ, Farmer AE. 1995. Genetic basis of schizophrenia. Lancet 346:678-682.
54. Meador-Woodruff JH, Davis KL, Haroutunian V. 2001. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology 24:545-552.
55. Moghaddam B, Adams BW. 1998. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352.
56. Moghaddam B, Adams B, Verma A, Daly D. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
57. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. 1999. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
58. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B, et al. 1995. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 11:321-324.
59. Monyer H, Seeburg PH, Wisden W. 1991. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron 6:799-810.
60. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221.
61. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heinemann SF. 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392:601-605.
62. Nakanishi S. 1994. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13:1031-1037.
63. Nishiguchi N, Shirakawa O, Ono H, Hashimoto T, Maeda K. 2000. Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am J Psychiat 157:1329-1331.
64. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. 1998. Expression of the human excitatory amino acid transporter 2 and metabotropic glutmnate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res 56:207-217.
65. Ohtsuki T, Sakurai K, Dou H, Toru M, Yamakawa-Kobayashi K, Arinami T. 2001a. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol Psychiatry 6:211-216.
66. Ohtsuki T, Toru M, Arinami T. 2001b. Mutation screening of the metabotropic glutamate receptor mGluR4 (GRM4) gene in patients with schizophrenia. Psychiatr Genet 11:79-83.
67. Pariseau C, Gregor P, Myles-Worsley M, Holik J, Hoff M, Waldo M, Freedman R, Coon H, Byerley W. 1994. Schizophrenia and glutamate receptor genes. Psychiatr Genet 4:161-165.
68. Pin JP, Duvoisin R. 1995. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26.
69. Porter RH, Eastwood SL, Harrison PJ. 1997. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 751:217-31.
70. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL, Kimberland M, Babb R, Vourlis S, Chen H, et al. 1995. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60:252-260.
71. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES. 2001. Linkage disequilibrium in the human genome. Nature 411:199-204.
72. Rice SR, Niu N, Berman DB, Heston LL, Sobell JL. 2001. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiat 6:274-284.
73. Richardson-Burns SM, Haroutunian V, Davis KL, Watson SJ, Meador-Woodruff JH. 2000. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus. Biol Psychiat 47:22-28.
74. Riley BP, McGuffin P. 2000. Linkage and associated studies of schizophrenia. Am J Med Genet 97:23-44.
75. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-856.
76. Rosenmund C, Stern-Bach Y, Stevens CF. 1998. The tetrameric structure of a glutamate receptor channel. Science 280:1596-1599.
77. Sakurai K, Toru M, Yamakawa-Kobayashi K, Arinami T. 2000. Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neurosci Lett. 296:168-170.
78. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, Segman RH, Hanses C, Freymann J, Yakir A, Trixler M, Falkai P, Rietschel M, Maier W, Wildenauer DB. 2000. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiat 5:638-649.
79. Seong E, Seasholtz AF, Burmeister M. 2002. Mouse models for psychiatric disorders. Trends Genet 18:643-650.
80. Sham P. 1998. Statistics in Human Genetics. London: Arnold.
81. Sheng M, Kim MJ. 2002. Postsynaptic signaling and plasticity mechanisms. Science 298:776-780.
82. Shibata H, Joo A, Fujii Y, Tani A, Makino C, Hirata N, Kikuta R, Ninomiya H, Tashiro N, Fukumaki Y. 2001. Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia. Psychiatr Genet 11:139-144.
83. Shibata H, Shibata A., Ninomiya H., Tashiro N, Fukumaki Y. 2002. Association study of polymorphisms in the GluR6 kainate receptor gene (GRIK2) with schizophrenia. Psychiatr Res 113:59-67.
84. Snyder SH. 1980. Phencyclidine. Nature 285:355-356.
85. Sokolov BP. 1998. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible upregulation by typical neuroleptics. J Neurochem 71:2454-2464.
86. Sommer B, Kohler M, Sprengel R, Seeburg PH. 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11-19.
87. Song I, Huganir RL. 2002. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25:578-588.
88. Straub RE, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, O'Neill FA, Walsh D, Kendler KS. 2002. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol Psychiat 7:542-559.
89. Taillon-Miller P, Bauer-Sardina I, Saccone NL, Putzel J, Laitinen T, Cao A, Kere J, Pilia G, Rice JP, Kwok PY. 2000. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet 25:324-328.
90. Tani A, Kikuta R, Itoh K, Joo A, Shibata H, Ninomiya H, Tashiro N, Fukumaki Y. 2002. Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia. Schizophr Res 58:83-86.
91. Wenthold RJ, Trumpy VA, Zhu WS, Petralia RS. 1994. Biochemical and assembly properties of GluR6 and KA2, two members of the kainate receptor family, determined with subunit-specific antibodies. J Biol Chem 269:1332-1339.
92. Williams NM, Bowen T, Spurlock G, Norton N, Williams HJ, Hoogendoorn B, Owen MJ, O'Donovan MC. 2002. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Mol Psychiat 7:508-514.
93. Xie X, Ott J. 1993. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53:1107.